Why GLP-1 weight loss drugs are catching investor attention
SB Talks
English - November 08, 2023 22:29 - 17 minutes - 23.7 MB - ★★★★★ - 1 ratingInvesting Business News Business News advice brown finance stanford Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Meet the Investor Series: Justin Miller, Oaktree Capital Management
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
The RBA’s widely anticipated rate hike and where to from here? Driving factors behind Australia’s higher-than-expected inflation numbers Whether geopolitical risks impact portfolio positioning? The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/